AJES Pharmaceuticals, LLCMarch 29, 2018

FDA 483 - AJES Pharmaceuticals, LLC - March 29, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AJES Pharmaceuticals, LLC

Record Details

An FDA inspection of AJES Pharmaceuticals LLC in Copiague, NY, a dietary supplement manufacturer, revealed significant deficiencies in quality control. The firm failed to adequately test finished dietary supplements for identity, purity, strength, and composition, and did not establish proper identity specifications for components. These issues, including a repeat observation, indicate a lack of scientific rationale and documentation for ensuring product quality.

Company: AJES Pharmaceuticals, LLC
Inspection Date: March 29, 2018
Product Type: Other
Office: Division of Human and Animal Food Operations - East I
Person: Meredith P. Soehl (Investigator)

Open in Dashboard

ID · 6619e0de-6689-4275-9d2c-76410ccbcb6b